Met-Rx, AST To Place Warnings On "Andro" Products Under FTC Settlement
This article was originally published in The Tan Sheet
Executive Summary
Sports supplement marketers Met-Rx USA and AST Sports Science agree in individual settlements with the Federal Trade Commission to place warnings on their androstenedione ("andro") supplements as well as an additional warning on andro supplements also containing ephedra.
You may also be interested in...
Prop 65 Andro Settlements Include “Corrective Advertising” Provision
Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court
Prop 65 Andro Settlements Include “Corrective Advertising” Provision
Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court
Prop 65 Andro Settlements Include “Corrective Advertising” Provision
Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court